Systemic corticosteroid therapy--side effects and their management.
about
Short-course oral steroids alone for chronic rhinosinusitisShort-course oral steroids as an adjunct therapy for chronic rhinosinusitisThe chemokine CXCL13 is a key molecule in autoimmune myasthenia gravisHigh-risk corneal allografts: A therapeutic challengeStructures and mechanism for the design of highly potent glucocorticoidsA role for methotrexate in the management of non-infectious orbital inflammatory diseaseSelective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitroIdentification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements.Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease.An update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review.Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review.DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity.The "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammationNatural anti-inflammatory agents for pain reliefTaenia solium: Development of an Experimental Model of Porcine Neurocysticercosis.Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).Use of systemic steroid after successful macular surgery in eyes with epiretinal membrane: a randomized, controlled clinical study.Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease.The efficacy of sirolimus in the treatment of patients with refractory uveitisThe relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-ChronicCorticosteroid-sparing therapy: practice patterns among uveitis specialistsA review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation.Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease?Ocular morbidity associated with intravitreal triamcinolone acetonide.Does Chronic Corticosteroid Use Increase Risks of Readmission, Thromboembolism, and Revision After THA?Large increases in adipose triacylglycerol flux in Cushingoid CRH-Tg mice are explained by futile cyclingDexamethasone-mediated changes in adipose triacylglycerol metabolism are exaggerated, not diminished, in the absence of a functional GR dimerization domain.Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elementsRole of the retinal vascular endothelial cell in ocular diseaseImpact and indication of early systemic corticosteroids for very severe community-acquired pneumonia.Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USARational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.Evidence-based management of nasal polyposis by intranasal corticosteroids: from the cause to the clinic.Corticosteroid-use in primary and secondary brain tumour patients: a review.Biologic agents in experimental autoimmune uveitis.The role of mucosal healing in the treatment of patients with inflammatory bowel diseaseThe Sustained-Release Dexamethasone Implant: Expanding Indications in Vitreoretinal Disease.Side-effects of anti-inflammatory therapy in uveitis.Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy.
P2860
Q24185860-0D475DBF-EB00-41A6-B66D-7B37B4C9D375Q24185867-22EDEBA5-B51B-47AE-9262-207B7B88D38DQ24308609-47AC1362-6C2F-4AFD-8A53-C4E2D6437F6DQ26751483-1970E6E0-BA0A-4371-95C0-E14E0BA504A5Q27683537-B0C30822-B690-4D37-A03B-F9E231CB3AD9Q28360294-50AA40EE-03B0-47AC-A776-3FD0D21190E0Q28479065-2DCC5003-4A9E-4AD5-8692-81136E9ED5B5Q30540705-238CB0A1-F884-480D-BB93-59464A109494Q33617323-18536C88-2E99-470E-AF77-A3302E26DCEFQ33776074-F81466A8-D805-466A-A2D6-9E70D6BA6B57Q33910781-B1CE90A3-6021-4F41-BBA6-C2D970C0AB2BQ34100569-882D208B-9287-4164-8F57-89A136076071Q34293348-88AA288F-F9A0-47FB-BD76-B55E66113999Q34374054-844A7777-3AC3-4DA9-8520-3B9C42D58435Q34444693-DE5FE143-DE5C-4C41-8341-290DFA8AC923Q34488709-0B70CBC9-557F-4A31-BEEE-6E8A4185E461Q35030923-30A554D3-B3A9-4483-893D-B023617C68C1Q35359052-B51FC1C4-B985-452F-9D6D-98CDEA92CDE1Q35592042-9EA710DC-6A40-40F0-B605-60664F10BA89Q35593216-FAF40A91-9177-4068-A4BB-CD29FC3C8733Q35815301-BEACA340-16A9-4A3A-B9AE-C6226EA8E17CQ35828102-E96D77F7-0423-4A18-A890-CB944B760F8EQ35895945-6A8CDDA1-0C40-4FB0-B494-E51B6C823F94Q36428410-CF20DA57-886B-449C-85C4-B35FEF048749Q36482537-DC99C0B3-46A4-41B2-B3A2-3649301B6B2AQ36558609-ABC9958E-4D3D-47F2-86A6-B3169AFDDBCCQ36592819-0D36E88E-6DDD-425E-B703-7AD2FD93963FQ36699512-A64CE81C-2540-47F5-A02F-C91B2363F200Q36759651-8AE60D31-F093-45AD-BC0F-A6445B78F956Q36919959-3EB40C79-9481-4C19-9DF1-CF34857F7B96Q37124621-27BBDF00-154A-4750-B613-003725A0E549Q37315338-78C64C87-BB8D-4E68-8833-165AD556ACD5Q37346963-F0430F26-B3ED-402C-955C-AED6D113EB06Q37846443-1B489F70-AE44-4DBF-BF7D-ECE3B96E6A4BQ37942476-6AEB618A-0DDF-4BD6-8DAA-EB8AB1EA0950Q38089645-8AE1A858-1023-4BEA-909C-F91551615836Q38176299-6BC19DD3-6B50-4AC8-B398-E1F5A0F54697Q38198098-C5130409-B1A3-44BB-8F6F-B5268704925BQ38261127-35A626FB-2792-40A4-AEAF-93FC8B36DD92Q38286988-CD7907FC-30ED-4F87-84DC-DA3FC5D88DCC
P2860
Systemic corticosteroid therapy--side effects and their management.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Systemic corticosteroid therapy--side effects and their management.
@ast
Systemic corticosteroid therapy--side effects and their management.
@en
Systemic corticosteroid therapy--side effects and their management.
@nl
type
label
Systemic corticosteroid therapy--side effects and their management.
@ast
Systemic corticosteroid therapy--side effects and their management.
@en
Systemic corticosteroid therapy--side effects and their management.
@nl
prefLabel
Systemic corticosteroid therapy--side effects and their management.
@ast
Systemic corticosteroid therapy--side effects and their management.
@en
Systemic corticosteroid therapy--side effects and their management.
@nl
P2860
P356
P1476
Systemic corticosteroid therapy--side effects and their management.
@en
P2093
Stanbury RM
P2860
P304
P356
10.1136/BJO.82.6.704
P407
P577
1998-06-01T00:00:00Z